Breast Cancer and Immunology

Immunotherapy is the utilization of meds to animate an individual's own invulnerable framework to perceive and obliterate disease cells more viably. Immunotherapy can be utilized to treat a few sorts of breast cancer. A significant piece of the invulnerable framework is its capacity to hold itself back from assaulting typical cells in the body. To do this, it employments "designated spots," which are proteins on resistant cells that should be turned on (or off) to begin an insusceptible reaction. Breast Cancer cells occasionally utilize these designated spots to try not to be assaulted by the insusceptible framework. Medications that focus on these designated spot proteins, help to reestablish the resistant reaction against breast malignancy cells.

  • Pembrolizumab (Keytruda) for breast cancer
  • PD-L1 protein

Related Conference of Breast Cancer and Immunology

October 04-05, 2023

8th Global Summit on Cancer Science and Oncology

Barcelona, Spain
November 08-09, 2023

International Conference on Cancer Biology and Therapeutics

Budapest, Hungary
November 15-16, 2023

36th Conference on Preventive Oncology and Diagnostic Cancer

Edinburgh, Scotland
December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Breast Cancer and Immunology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in